PubMed

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.

Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.

Ann Intern Med. 1996 Dec 15;125(12):961-8.PMID: 8967706 [PubMed - indexed for MEDLINE]Related articlesFree article

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.

Osteoporos Int. 2006;17(5):716-23. Epub 2006 Feb 3.PMID: 16463007 [PubMed - indexed for MEDLINE]Related articles

Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.

Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.

J Rheumatol. 1997 Aug;24(8):1489-94.PMID: 9263140 [PubMed - indexed for MEDLINE]Related articles

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.

J Bone Miner Res. 2004 Aug;19(8):1221-30. Epub 2004 May 24.PMID: 15231008 [PubMed - indexed for MEDLINE]Related articles

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.

Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA.

Ann Intern Med. 1993 Nov 15;119(10):963-8.PMID: 8105737 [PubMed - indexed for MEDLINE]Related articlesFree article

A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention.

Viljakainen HT, Natri AM, Kärkkäinen M, Huttunen MM, Palssa A, Jakobsen J, Cashman KD, Mølgaard C, Lamberg-Allardt C.

J Bone Miner Res. 2006 Jun;21(6):836-44.PMID: 16753014 [PubMed - indexed for MEDLINE]Related articles

Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.

Frediani B, Falsetti P, Baldi F, Acciai C, Filippou G, Marcolongo R.

Bone. 2003 Oct;33(4):575-81.PMID: 14555261 [PubMed - indexed for MEDLINE]Related articles

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA.

N Engl J Med. 1997 Aug 7;337(6):382-7.PMID: 9241127 [PubMed - indexed for MEDLINE]Related articlesFree article

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.

Reid DM, Adami S, Devogelaer JP, Chines AA.

Calcif Tissue Int. 2001 Oct;69(4):242-7.PMID: 11730260 [PubMed - indexed for MEDLINE]Related articles

Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?

van Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW.

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):155-60.PMID: 12747268 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.

Cortet B, Hachulla E, Barton I, Bonvoisin B, Roux C.

Rev Rhum Engl Ed. 1999 Apr;66(4):214-9.PMID: 10339777 [PubMed - indexed for MEDLINE]Related articles

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.

Pitt P, Li F, Todd P, Webber D, Pack S, Moniz C.

Thorax. 1998 May;53(5):351-6.PMID: 9708225 [PubMed - indexed for MEDLINE]Related articlesFree article

Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.

Geusens P, Dequeker J, Vanhoof J, Stalmans R, Boonen S, Joly J, Nijs J, Raus J.

Ann Rheum Dis. 1998 Dec;57(12):724-7.PMID: 10070271 [PubMed - indexed for MEDLINE]Related articlesFree article

Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.

Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD.

Arthritis Rheum. 2008 Oct;58(10):3255-63.PMID: 18821668 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.

Eastell R, Devogelaer JP, Peel NF, Chines AA, Bax DE, Sacco-Gibson N, Nagant de Deuxchaisnes C, Russell RG.

Osteoporos Int. 2000;11(4):331-7.PMID: 10928223 [PubMed - indexed for MEDLINE]Related articles

The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.

Tascioglu F, Colak O, Armagan O, Alatas O, Oner C.

Rheumatol Int. 2005 Nov;26(1):21-9. Epub 2005 Feb 2.PMID: 15688191 [PubMed - indexed for MEDLINE]Related articles

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.

Ann Rheum Dis. 2009 Mar;68(3):373-6. Epub 2008 Apr 13.PMID: 18408246 [PubMed - indexed for MEDLINE]Related articlesFree article

Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial.

Daly RM, Brown M, Bass S, Kukuljan S, Nowson C.

J Bone Miner Res. 2006 Mar;21(3):397-405. Epub 2005 Dec 19.PMID: 16491287 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.

Healey JH, Paget SA, Williams-Russo P, Szatrowski TP, Schneider R, Spiera H, Mitnick H, Ales K, Schwartzberg P.

Calcif Tissue Int. 1996 Feb;58(2):73-80.PMID: 8998681 [PubMed - indexed for MEDLINE]Related articles

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A.

Arthritis Rheum. 2001 Jan;44(1):202-11.PMID: 11212161 [PubMed - indexed for MEDLINE]Related articlesFree article